Telmisartan
- OralTelmisartanMicardis
- Mechanism of Action
- Competitively inhibits the action of angiotensin II at AT1 receptors.
Clinical Use
- Indication
- Hypertension – first line management, especially in patients with chronic kidney disease (CKD)
- Contraindications
- Adverse Effects